Telomere dysfunction and cell survival: Roles for distinct TIN2-containing complexes

Journal of Cell Biology

Volumn 181, Issue 3, 2008, Pages 447-460

  Kim, Sahn Ho ^a,c   Davalos, Albert R ^a   Heo, Seok Jin ^a   Rodier, Francis ^a   Zou, Ying ^a   Beausejour, Christian ^a,d   Kaminker, Patrick ^b,e   Yannone, Steven M ^a   Campisi, Judith ^a,b  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^c HENRY FORD HEALTH SYSTEM   (United States)

^d UNIVERSITY OF MONTREAL   (Canada)

^e GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; PROTEIN TIN2; RAP1 PROTEIN; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2;

ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; TELOMERE;

ANIMALS; CELL AGING; CELL LINE; CELL SURVIVAL; CHROMOSOME ABERRATIONS; ENDOPEPTIDASES; HUMANS; MACROMOLECULAR SUBSTANCES; MICE; MUTATION; TELOMERASE; TELOMERE; TELOMERE-BINDING PROTEINS; TELOMERIC REPEAT BINDING PROTEIN 1; TELOMERIC REPEAT BINDING PROTEIN 2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 43149085538     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200710028     Document Type: Article

References (51)

1. Bailey, S.M., J. Meyne, D.J. Chen, A. Kurimasa, G.C. Li, B.E. Lehnert, and E.H. Goodwin. 1999. DNA double-strand break repair proteins are required to cap the ends of mammalian chromosomes. Proc. Natl. Acad. Sci. USA. 96:14899-14904.
2. Baumann, P., and T.R. Cech. 2001. Pot1, the putative telomere end-binding protein in fission yeast and humans. Science. 292:1171-1175.
3. Baumann, P., E. Podell, and T.R. Cech. 2002. Human Pot1 (protection of telomeres) protein: cytolocalization, gene structure, and alternative splicing. Mol. Cell. Biol. 22:8079-8087.
4. Beausejour, C.M., A. Krtolica, F. Galimi, M. Narita, S.W. Lowe, P. Yaswen, and J. Campisi. 2003. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 22:4212-4222.
5. Bianchi, A., R.M. Stansel, L. Fairall, J.D. Griffith, D. Rhodes, and T. de Lange. 1999. TRF1 binds a bipartite telomeric site with extreme spatial flexibility. EMBO J. 18:5735-5744.
6. Blackburn, E.H. 2000. Telomere states and cell fates. Nature. 408:53-56.
7. Brummelkamp, T.R., R. Bernards, and R. Agami. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science. 296:550-553.
8. Celli, G.B., and T. de Lange. 2005. DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nat. Cell Biol. 7:712-718.
9. Chang, W., J.N. Dynek, and S. Smith. 2003. TRF1 is degraded by ubiquitin-mediated proteolysis after release from telomeres. Genes Dev. 17:1328-1333.
10. Chiang, Y.J., S.H. Kim, L. Tessarollo, J. Campisi, and R.J. Hodes. 2004. Telomere-associated protein TIN2 is essential for early embryonic development through a telomerase-independent pathway. Mol. Cell. Biol. 24:6631-6634.
11. Chin, L., S.E. Artandi, Q. Shen, A. Tam, S.L. Lee, G.J. Gottlieb, C.W. Greider, and R.A. DePinho. 1999. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell. 97:527-538.
12. d'Adda di Fagagna, F., P.M. Reaper, L. Clay-Farrace, H. Fiegler, P. Carr, T. Von Zglinicki, G. Saretzki, N.P. Carter, and S.P. Jackson. 2003. A DNA damage checkpoint response in telomere-initiated senescence. Nature. 426:194-198.
13. Davalos, A.R., and J. Campisi. 2003. Bloom syndrome cells undergo p53-dependent apoptosis and delayed assembly of BRCA1 and NBS1 repair complexes at stalled replication forks. J. Cell Biol. 162:1197-1209.
14. de Lange, T. 2005. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 19:2100-2110.
15. Dignam, J.D., R.M. Lebovitz, and R.G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
16. Dimri, G.P., X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E.E. Medrano, M. Linskens, I. Rubelj, O. Pereira-Smith, et al. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA. 92:9363-9367.
17. Dull, T., R. Zufferey, M. Kelly, R.J. Mandel, M. Nguyen, D. Trono, and L. Naldini. 1998. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72:8463-8471.
18. Goldstein, J.C., F. Rodier, J.C. Garbe, M.R. Stampfer, and J. Campisi. 2005. Caspase-independent cytochrome c release is a sensitive measure of low-level apoptosis in cell culture models. Aging Cell. 4:217-222.
19. Griffith, J.D., L. Comeau, S. Rosenfield, R.M. Stansel, A. Bianchi, H. Moss, and T. de Lange. 1999. Mammalian telomeres end in a large duplex loop. Cell. 97:503-514 (see comments).
20. Gudkov, A.V., C.R. Zelnick, A.R. Kazarov, R. Thimmapaya, D.P. Suttle, W.T. Beck, and I.B. Roninson. 1993. Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA. Proc. Natl. Acad. Sci. USA. 90:3231-3235.
21. Guiducci, C., M.A. Cerone, and S. Bacchetti. 2001. Expression of mutant telomerase in immortal telomerase-negative human cells results in cell cycle deregulation, nuclear and chromosomal abnormalities and rapid loss of viability. Oncogene. 20:714-725.
22. Hahn, W.C., S.A. Stewart, M.W. Brooks, S.G. York, E. Eaton, A. Kurachi, R.L. Beijersbergen, J.H. Knoll, M. Meyerson, and R.A. Weinberg. 1999. Inhibition of telomerase limits the growth of human cancer cells. Nat. Med. 5: 1164-1170.
23. Herbig, U., W.A. Jobling, B.P. Chen, D.J. Chen, and J.M. Sedivy. 2004. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol. Cell. 14:501-513.
24. Hockemeyer, D., A.J. Sfeir, J.W. S hay, W.E. Wright, and T. de Lange. 2 005. POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end. EMBO J. 24:2667-2678.
25. Hockemeyer, D., J.P. Daniels, H. Takai, and T. de Lange. 2006. Recent expansion of the telomeric complex in rodents: Two distinct POT1 proteins protect mouse telomeres. Cell. 126:63-77.
26. Houghtaling, B.R., L. Cuttonaro, W. Chang, and S. Smith. 2004. A dynamic molecular link between the telomere length regulator TRF1 and the chromosome end protector TRF2. Curr. Biol. 14:1621-1631.
27. Hultdin, M., E. Gronlund, K. Norrback, E. Eriksson-Lindstrom, T. Just, and G. Roos. 1998. Telomere analysis by fluorescence in situ hybridization and flow cytometry. Nucleic Acids Res. 26:3651-3656.
28. Iwano, T., M. Tachibana, M. Reth, and Y. Shinkai. 2004. Importance of TRF1 for functional telomere structure. J. Biol. Chem. 279:1442-1448.
29. Karlseder, J., D. Broccoli, Y. Dai, S. Hardy, and T. de Lange. 1999. p53-and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science. 283:1321-1325.
30. Kim, S.H., P. Kaminker, and J. Campisi. 1999. TIN2, a new regulator of telomere length in human cells. Nat. Genet. 23:405-412.
31. Kim, S.H., S. Han, Y.H. You, D.J. Chen, and J. Campisi. 2003. The human telomere-associated protein TIN2 stimulates interactions between telomeric DNA tracts in vitro. EMBO Rep. 4:685-691.
32. Kim, S.H., C. Beausejour, A.R. Davalos, P. Kaminker, S.J. Heo, and J. Campisi. 2004. TIN2 mediates functions of TRF2 at human telomeres. J. Biol. Chem. 279:43799-43804.
33. Li, S., J.E. Rosenberg, A.A. Donjacour, I.L. Botchkina, Y.K. Hom, G.R. Cunha, and E.H. Blackburn. 2004. Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA. Cancer Res. 64:4833-4840.
34. Liu, D., M.S. O'Connor, J. Qin, and Z. Songyang. 2004a. Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins. J. Biol. Chem. 279:51338-51342.
35. Liu, D., A. Safari, M.S. O'Connor, D.W. Chan, A. Laegeler, J. Qin, and Z. Songyang. 2004b. PTOP interacts with POT1 and regulates its localization to telomeres. Nat. Cell Biol. 6:673-680.
36. Loayza, D., and T. De Lange. 2003. POT1 as a terminal transducer of TRF1 telomere length control. Nature. 423:1013-1018.
37. Nair, A.R., M. Schliekelman, M.B. Thomas, J. Wakefield, S. Jurgensen, and R. Ramabhadran. 2005. Inhibition of p53 by lentiviral mediated shRNA abrogates G1 arrest and apoptosis in retinal pigmented epithelial cell line. Cell Cycle. 4:697-703.
38. O'Connor, M.S., A. Safari, H. Xin, D. Liu, and Z. Songyang. 2006. A critical role for TPP1 and TIN2 interaction in high-order telomeric complex assembly. Proc. Natl. Acad. Sci. USA. 103:11874-11879.
39. Okabe, J., A. Eguchi, R. Wadhwa, R. Rakwal, R. Tsukinoki, T. Hayakawa, and M. Nakanishi. 2004. Limited capacity of the nuclear matrix to bind telomere repeat binding factor TRF1 may restrict the proliferation of mortal human fibroblasts. Hum. Mol. Genet. 13:285-293.
40. Rodier, F., S.H. Kim, T. Nijjar, P. Yaswen, and J. Campisi. 2005. Cancer and aging: the importance of telomeres in genome maintenance. Int. J. Biochem. Cell Biol. 37:977-990.
41. Smogorzewska, A., and T. De Lange. 2002. Different telomere damage signaling pathways in human and mouse cells. EMBO J. 21:4338-4348.
42. Smogorzewska, A., and T. de Lange. 2004. Regulation of telomerase by telomeric proteins. Annu. Rev. Biochem. 73:177-208.
43. Takai, H., A. Smogorzewska, and T. de Lange. 2003. DNA damage foci at dysfunctional telomeres. Curr. Biol. 13:1549-1556.
44. van Steensel, B., and T. de Lange. 1997. Control of telomere length by the human telomeric protein TRF1. Nature. 385:740-743.
45. van Steensel, B., A. Smogorzewska, and T. de Lange. 1998. TRF2 protects human telomeres from end-to-end fusions. Cell. 92:401-413.
46. Wu, L., A.S. Multani, H. He, W. Cosme-Blanco, Y. Deng, J.M. Deng, O. Bachilo, S. Pathak, H. Tahara, S.M. Bailey, et al. 2006. Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres. Cell. 126:49-62.
47. Xin, H., D. Liu, M. Wan, A. Safari, H. Kim, W. Sun, M.S. O'Connor, and Z. Songyang. 2007. TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature. 445:559-562.
48. Yang, Q., Y.L. Zheng, and C.C. Harris. 2005. POT1 and TRF2 cooperate to maintain telomeric integrity. Mol. Cell. Biol. 25:1070-1080.
49. Ye, J.Z., J.R. Donigian, M. van Overbeek, D. Loayza, Y. Luo, A.N. Krutchinsky, B.T. Chait, and T. d e Lange. 2 004a. TIN2 binds TRF1 and TRF2 simultaneously and stabilizes the TRF2 complex on telomeres. J. Biol. Chem. 279:47264-47271.
50. Ye, J.Z., D. Hockemeyer, A.N. Krutchinsky, D. Loayza, S.M. Hooper, B.T. Chait, and T. de Lange. 2004b. POT1-interacting protein PIP1: a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex. Genes Dev. 18:1649-1654.
51. Zou, Y., A. Sfeir, S.M. Gryaznov, J.W. Shay, and W.E. Wright. 2004. Does a sentinel or a subset of short telomeres determine replicative senescence? Mol. Biol. Cell. 15:3709-3718